Preliminary Results of 9MW2821 Targeting Nectin-4ADC in Adva

The preliminary results of the phase I/II study evaluating the safety, tolerability, and preliminary efficacy of 9MW2821, a Nectin-4-targeting antibody-drug conjugate (ADC)

Related Keywords

Spain , Madrid , Jian Zhang , European Society For Medical Oncology , Fudan University Cancer Hospital , Professor Jian Zhang , European Society , Medical Oncology ,